CN106822844A - A kind of Chinese medicine composition of prevention glioma postoperative recurrence - Google Patents
A kind of Chinese medicine composition of prevention glioma postoperative recurrence Download PDFInfo
- Publication number
- CN106822844A CN106822844A CN201710156755.4A CN201710156755A CN106822844A CN 106822844 A CN106822844 A CN 106822844A CN 201710156755 A CN201710156755 A CN 201710156755A CN 106822844 A CN106822844 A CN 106822844A
- Authority
- CN
- China
- Prior art keywords
- parts
- gypsum
- radix
- draconis
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Chinese medicine composition the present invention relates to prevent glioma postoperative recurrence, can effectively be solved the problems, such as to prevent the medication of glioma postoperative recurrence, and method is made up of the material medicine of following parts by weight meter:18 parts of Radix Codonopsis, 15 parts of the root of large-flowered skullcap, 15 parts of Os Draconis, 15 parts of raw oyster, 1 15 parts of cassia twig, 1 10 parts of Poria cocos, 15 parts of prepared RHIZOMA PINELLIZE without adju-vant, 18 parts of radix bupleuri, 1 15 parts of rheum officinale, fry two ugly 15 parts, 17 parts of moutan bark, 1 15 parts of gypsum, 15 parts of gypsum rubrum, 17 parts of rhizoma zingiberis, 17 parts of great Bei, 1 10 parts of radix scrophulariae, 15 parts of 18 parts of licorice and date, instant component is scientific and reasonable, preparation method is simple, it is easy to operate, low cost, it is convenient to take, effect is good, it is prepared by easily production, it is to prevent the innovation on glioma postoperative recurrence medicine, there is good economic and social benefit.
Description
Technical field
The present invention relates to medicine, particularly a kind of Chinese medicine composition of prevention glioma postoperative recurrence.
Background technology
Glioma is the primary tumor caused by brain and spinal cord spongiocyte canceration, be central nervous system the most
One of common tumour, accounts for the 30-50% of intracranial tumour, and with the incidence of disease is high, high recurrence rate, the death rate be high, cure rate is low
Feature, its pathogenesis etiology still indefinite so far.Chinese glioma annual morbidity is 3-6 people/100,000 people, is fallen ill in recent years
In rejuvenation trend, at 30-40 Sui, children's morbidity in 10 years old or so is also more in addition on age of onset peak.
To glioma still with surgery excision as essential therapeutic arsenals, supplemented by radiotherapy, chemotherapy, but because glioma is in
The unrestricted hyperplasia of existing wellability, shortage apoptosis, and without obvious boundary between normal cerebral tissue, multiple cerebral lobes are invaded, or even invade
Brain deep critical function area, it is thorough that operation is difficult to excision;Again because brain glioblastoma cell is insensitive to ray, chemotherapeutics is again difficult
Through blood-brain barrier and with drug resistance, to cause the clinical radiation therapy of glioma and chemotherapy effect undesirable, thus have
Recurrence rate very high, 6 months mean survival time (MST)s, complex treatment life cycle was less than 2 years.Chinese medicine this disease has unique curative effect,
Particularly prevention of postoperative recurrence.Traditional Chinese medicine thinks that this disease is mainly spleen kidney deficiency, wind phlegm condensation, ecchymosis internal resistance, healthy tendency virtual loss, many
Treated with strengthening spleen, tonifying kidney method.But current surgery excision, radiotherapy, chemotherapy are the high method for attacking heresy fiercely, the healthy tendency that can be damaged patient
More exhaustion, is unfavorable for recovery and the extension patient survival of disease.
Though the existing multi-medicament for having a Prevention glioma postoperative recurrence, for various reasons, particularly medicine
Problem present on composition, it is used and unsatisfactory, therefore develops the medicine of new Prevention glioma postoperative recurrence
It is imperative.
The content of the invention
For above-mentioned situation, for the purpose for overcoming the defect of prior art, the present invention is just to provide a kind of prevention brain colloid
The Chinese medicine composition of knurl postoperative recurrence, can effectively solve the problems, such as to prevent the medication of glioma postoperative recurrence.
The technical scheme that the present invention is solved is that a kind of Chinese medicine composition for preventing glioma postoperative recurrence is by following weight
The material medicine of number meter is made:Radix Codonopsis 1-8 parts, root of large-flowered skullcap 1-5 parts, Os Draconis 1-5 parts, raw oyster 1-5 parts, cassia twig 1-15 parts,
Poria cocos 1-10 parts, prepared RHIZOMA PINELLIZE without adju-vant 1-5 parts, radix bupleuri 1-8 parts, rheum officinale 1-15 parts, fry two ugly 1-5 parts, moutan bark 1-7 parts, gypsum 1-
15 parts, gypsum rubrum 1-5 parts, rhizoma zingiberis 1-7 parts, great Bei 1-7 parts, radix scrophulariae 1-10 parts, licorice 1-8 parts and date 1-5 parts, wherein,
To first be mixed except other 16 taste material medicines of Os Draconis, raw oyster, add other 16 taste material medicine weight 7-10
Water again, soaks 30-60min;Os Draconis, raw oyster are mixed, plus Os Draconis, the water of 7-10 times of raw oyster weight,
Immersion 30-60min, decocts 30-40min, in other the 16 taste material medicines poured into after immersion 30-60min, then decocts 30-
40min, filtering, obtains first time filtrate;The dregs of a decoction add the water of 7-10 times of material medicine weight, decoct 30-40min, filter
Second filtrate, merges filtrate twice, is mixed into Chinese medicine liquid, waits to take.
Instant component is scientific and reasonable, and preparation method is simple, and easy to operate, low cost is convenient to take, and effect is good, easily production
Prepare, be to prevent the innovation on glioma postoperative recurrence medicine, there is good economic and social benefit.
Specific embodiment
Specific embodiment of the invention is elaborated with reference to embodiments.
The present invention can be realized in specific implementation by following examples.
Embodiment 1
In specific implementation, a kind of Chinese medicine composition for preventing glioma postoperative recurrence is by following parts by weight meter for the present invention
Material medicine is made:7 parts of Radix Codonopsis, 4 parts of the root of large-flowered skullcap, 4 parts of Os Draconis, 4 parts of raw oyster, 8 parts of cassia twig, 8 parts of Poria cocos, 4 parts of prepared RHIZOMA PINELLIZE without adju-vant, bavin
6 parts recklessly, 9 parts of rheum officinale, ugly 4 parts of stir-fry two, 6 parts of moutan bark, 9 parts of gypsum, 4 parts of gypsum rubrum, 6 parts of rhizoma zingiberis, 5 parts of great Bei, radix scrophulariae 8
3 parts of part, 6 parts of licorice and date, wherein, will first be mixed except other 16 taste material medicines of Os Draconis, raw oyster, plus
Enter the water of other 7-10 times of 16 taste material medicine weight, soak 30-60min;Os Draconis, raw oyster are mixed, plus it is raw
The water of keel, 7-10 times of raw oyster weight, soaks 30-60min, decocts 30-40min, pours into other after immersion 30-60min
In 16 taste material medicines, then 30-40min is decocted, filtered, obtain first time filtrate;The dregs of a decoction add 7-10 times of material medicine weight
Water, decoct 30-40min, filter to obtain second filtrate, merge filtrate twice, be mixed into Chinese medicine liquid, wait to take.
Embodiment 2
In specific implementation, a kind of Chinese medicine composition for preventing glioma postoperative recurrence is by following parts by weight meter for the present invention
Material medicine is made:5 parts of Radix Codonopsis, 6 parts of the root of large-flowered skullcap, 3 parts of Os Draconis, 3 parts of raw oyster, 5 parts of cassia twig, 3 parts of Poria cocos, 6 parts of prepared RHIZOMA PINELLIZE without adju-vant, bavin
4 parts recklessly, 5 parts of rheum officinale, ugly 6 parts of stir-fry two, 4 parts of moutan bark, 5 parts of gypsum, 6 parts of gypsum rubrum, 3 parts of rhizoma zingiberis, 3 parts of great Bei, radix scrophulariae 6
6 parts of part, 4 parts of licorice and date, preparation method is with embodiment 1.
Embodiment 3
In specific implementation, a kind of Chinese medicine composition for preventing glioma postoperative recurrence is by following parts by weight meter for the present invention
Material medicine is made:3 parts of Radix Codonopsis, 4 parts of the root of large-flowered skullcap, 2 parts of Os Draconis, 2 parts of raw oyster, 4 parts of cassia twig, 4 parts of Poria cocos, 2 parts of prepared RHIZOMA PINELLIZE without adju-vant, bavin
3 parts recklessly, 4 parts of rheum officinale, ugly 3 parts of stir-fry two, 5 parts of moutan bark, 7 parts of gypsum, 3 parts of gypsum rubrum, 5 parts of rhizoma zingiberis, 3 parts of great Bei, radix scrophulariae 2
5 parts of part, 8 parts of licorice and date, preparation method is with embodiment 1.
Embodiment 4
In specific implementation, a kind of Chinese medicine composition for preventing glioma postoperative recurrence is by following parts by weight meter for the present invention
Material medicine is made:2 parts of Radix Codonopsis, 3 parts of the root of large-flowered skullcap, 3 parts of Os Draconis, 3 parts of raw oyster, 2 parts of cassia twig, 2 parts of Poria cocos, 3 parts of prepared RHIZOMA PINELLIZE without adju-vant, bavin
3 parts recklessly, 2 parts of rheum officinale, ugly 2 parts of stir-fry two, 2 parts of moutan bark, 6 parts of gypsum, 2 parts of gypsum rubrum, 3 parts of rhizoma zingiberis, 2 parts of great Bei, radix scrophulariae 3
Part, 3 parts of licorice, 5 parts of date, preparation method is with embodiment 1.
Embodiment 5
In specific implementation, a kind of Chinese medicine composition for preventing glioma postoperative recurrence is by the raw material of following weight meter for the present invention
Medicine is made:Radix Codonopsis 100g, root of large-flowered skullcap 100g, Os Draconis 300g, raw oyster 300g, cassia twig 100g, Poria cocos 120g, prepared RHIZOMA PINELLIZE without adju-vant
100g, radix bupleuri 100g, rheum officinale 100g, fry two ugly 60g, moutan bark 100g, gypsum 300g, gypsum rubrum 100g, rhizoma zingiberis 100g, greatly
Shellfish 100g, radix scrophulariae 300g, licorice 60g and date 200g, preparation method is with embodiment 1.
Embodiment 6
In specific implementation, a kind of Chinese medicine composition for preventing glioma postoperative recurrence is by the raw material of following weight meter for the present invention
Medicine is made:Radix Codonopsis 200g, root of large-flowered skullcap 200g, Os Draconis 100g, raw oyster 100g, cassia twig 200g, Poria cocos 150g, prepared RHIZOMA PINELLIZE without adju-vant
200g, radix bupleuri 200g, rheum officinale 200g, fry two ugly 100g, moutan bark 200g, gypsum 100g, gypsum rubrum 200g, rhizoma zingiberis 200g,
Great Bei 200g, radix scrophulariae 100g, licorice 100g and date 100g, preparation method is with embodiment 1.
Embodiment 7
In specific implementation, a kind of Chinese medicine composition for preventing glioma postoperative recurrence is by the raw material of following weight meter for the present invention
Medicine is made:Radix Codonopsis 50g, root of large-flowered skullcap 50g, Os Draconis 150g, raw oyster 150g, cassia twig 50g, Poria cocos 50g, prepared RHIZOMA PINELLIZE without adju-vant 60g, radix bupleuri
60g, rheum officinale 60g, fry two ugly 30g, moutan bark 50g, gypsum 150g, gypsum rubrum 50g, rhizoma zingiberis 50g, great Bei 60g, radix scrophulariae
150g, licorice 100g and date 80g, preparation method is with embodiment 1.
Embodiment 8
In specific implementation, a kind of Chinese medicine composition for preventing glioma postoperative recurrence is by the raw material of following weight meter for the present invention
Medicine is made:Radix Codonopsis 30g, root of large-flowered skullcap 30g, Os Draconis 80g, raw oyster 80g, cassia twig 30g, Poria cocos 40g, prepared RHIZOMA PINELLIZE without adju-vant 40g, radix bupleuri
20g, rheum officinale 30g, fry two ugly 20g, moutan bark 30g, gypsum 50g, gypsum rubrum 40g, rhizoma zingiberis 30g, great Bei 30g, radix scrophulariae 20g,
Licorice 30g and date 30g, preparation method is with embodiment 1.
In above-mentioned raw materials medicine, wherein:
Radix Codonopsis, is the dry root of Campanulaceae Radix Codonopsis, sweet, flat, returns spleen, lung channel;Strengthening spleen and tonifying lung, nourishes blood and promotes the production of body fluid;For spleen
Lung Qi deficiency, eat less and tired, false asthma cough, insufficiency of vital energy and blood, sallow complexion, palpitation.
The root of large-flowered skullcap, is the dry root of the labiate root of large-flowered skullcap, bitter, cold, return lung, courage, spleen, large intestine, small intestinl channel;Heat-clearing is dry
It is wet, purging intense heat and detonicating, hemostasis, antiabortive;For damp-warm syndrome, summer-heat and damp, evil of vomitting uncomfortable in chest, damp and hot feeling of fullness, rush down dysentery, jaundice, cough with lung heat, hyperpyrexia
Polydipsia, blood-head tells nosebleed, carbuncle sore tumefacting virus, fetal irritability.
Os Draconis, are Skeletal Fossils of the ancient times mammal like an elephant class, rhinoceros class, Hippocampal cortex etc., sweet, puckery, flat, are returned
The heart, liver, kidney, large intestine channel;Calming the liver, tranquillizing the mind by relieving convulsion is astringent or styptic treatment for spontaneous sweating;For frightened epilepsy it is demented, palpitation is forgetful, insomnia and dreamful sleep, spontaneous perspiration steal
Sweat, seminal emission stranguria with turbid discharge, hematemesis is had blood in stool, uterine bleeding under band, rush down dysentery prolapse of the anus, ulcer do not close up long.
Raw oyster, is the shell of Ostreidae animal Crassostrea rivularis, oyster long or ostrea talienwhanensis Crosse etc., and taste is salty, be slightly cold, and is returned
Liver, courage, kidney channel;Beneficial the moon checking exuberance of yang, softening and resolving hard mass is astringent or styptic treatment for spontaneous sweating;For insomnia of palpitating with fear, dizziness and tinnitus, scrofula subcutaneous nodule, abdominal lump of mass in abdomen, from
Sweat night sweat, seminal emission collapse band, stomachache pantothenic acid.
Cassia twig, is the dry twig of canella Chinese cassia tree, taste is pungent, sweet, temperature, the thoughts of returning home, lung, bladder warp;Sweating expelling pathogenic factors from muscles and skin, Wen Tong
Passages through which vital energy circulates, helps yang transforming qi, flat gas that spins;For anemofrigid cold, coldness and pain in the epigastrium, thromboembolism Amenorrhea, joint pain, phlegm and retained fluid oedema, palpitaition
Run quickly globefish.
Poria cocos, is the dry sclerotia of On Polyporaceae Poria cocos, sweet, light, flat, the thoughts of returning home, lung, spleen, kidney channel;Li Shui oozes
Wet, invigorating the spleen calming heart;For oedema oliguria, phlegm retention anti-dazzle nervous, spleen eating less, loose stool diarrhea, confused and worried, insomnia of palpitating with fear.
Prepared RHIZOMA PINELLIZE without adju-vant, is the dry tuber of aroid prepared RHIZOMA PINELLIZE without adju-vant, taste is pungent, temperature, returns spleen, stomach, lung channel;Eliminating dampness and eliminating phlegm,
Stopping nausea and vomiting by lowering the adverse flow of QI, dissolving lump and resolving mass;For the cold phlegm of damp phlegm, cough and phlegm, phlegm retention anti-dazzle nervous, anemophlegmatic vertigo, coma due to blocking of the respiratory system headache, vomiting gastric disorder causing nausea,
Chest gastral cavity ruffian, globus hysteriocus.
Radix bupleuri, is the dry root of umbelliferae bupleurum or radix bupleuri scorzoneraefolii, taste is pungent, hardship, is slightly cold, Return liver, courage, lung channel;Dredge
Dissipate bring down a fever, soothing liver-qi stagnation, rise lift yang-energy;For cold, fever, fevers and chills alternate, distending pain in the chest and hypochondrium, irregular menstruation, the prolapse of uterus, de-
Anus.
Rheum officinale, is the dry root and rhizome of polygonum rheum palmatum, Rheum tanguticum Maxim or Rheum officinale, bitter, cold, is returned
Spleen, stomach, large intestine, liver, pericardium channel;Heat and toxic materials clearing away, clearing heat-fire, removing pattogenic heat from the blood and toxic material from the body, dispelling stasis of blood and stimulating the menstrual flow, removing dampness through diuresis and removing jaundice;For damp and hot product
Stagnant constipation, blood-head tells nosebleed, hot eyes pharynx swelling, carbuncle swells furunculosis, abdominalgia with intestinal abscess, blood stasis closed, postpartum stasis, traumatic injury, hygropyretic dysentery
The red urine of disease, jaundice, stranguria oedema.
Fry two ugly, be the dry mature fruit that convolvulaceous plant pharbitis nilChoisy or garden leaf are led a cow, it is bitter, cold, return lung, kidney,
Large intestine channel;Water pouring defaecation, dissolving phlegm are washed drink, desinsection and attack product.Gathered for oedema turgor, constipation and anuresis, phlegm and retained fluid, the circulation of vital energy in the wrong direction is breathed with cough, worm
Product stomachache.
Moutan bark, is the dry root skin of ranunculaceae peony, taste is pungent, is slightly cold, the thoughts of returning home, liver and kidney channel;Clearing heat and cooling blood, it is living
Blood stagnation resolvation;Enter ying blood, febrile virulent maculae, hematemesis and epistaxis, night fever abating at dawn, lossless hectic fever due to yin, closed dysmenorrhea, the pain of injury caused by falling and tumbling, carbuncle for heat
Swollen sore.
Gypsum, is Sulfates mineral anhydrite race gypsum, in sweet, pungent, Great Cold, is attached to the lung and stomach meridians;Clearing heat-fire, remove
It is tired to quench the thirst;For fever caused by exogenous pathogenic factors, hyperpyrexia polydipsia, dyspnea and cough due to lung-heat, the high Sheng of stomach fire, headache, toothache.
Gypsum rubrum, is calcium sulfate or calcium carbonate mineral, taste is pungent, salty, cold, the thoughts of returning home, stomach, kidney channel;Clearing heat-fire, sharp key, disappears
It is swollen;For pyreticosis polydipsia, erysipelas is scalded.
Rhizoma zingiberis, is the dry rhizome of zingiber, taste is pungent, heat, returns spleen, stomach, kidney, the heart, lung channel;Warm cold dispelling, Hui Yang
Promote blood circulation, Wenfei of drink;Breathed with cough for coldness and pain in the epigastrium, vomiting is had loose bowels, cold, the cold drink of the cold arteries and veins of limb.
Great Bei, is the dry bulb of liliaceous plant fritillary bulb, bitter, it is sweet, be slightly cold, return lung, the heart channel of Hang-Shaoyin;Clearing heat and moistening lung, change
Phlegm and relieving cough;Coughed for lung-heat type cough, the few phlegm of dry cough, deficiency of Yin labor, cough sputum streaked with blood.
Radix scrophulariae, is the dry root of goatweed radix scrophulariae, sweet, bitter, salty, be slightly cold, return lung, stomach, kidney channel;Clearing heat and cooling blood,
Nourishing Yin and falling fire, detoxicating and resolving a mass;For heat enter ying blood, febrile virulent maculae, consumption of YIN caused by febrile disease, the deep red polydipsia of tongue, Tianjin hinder constipation, hectic fever due to yin labor is coughed,
Hot eyes pharyngalgia, diphtheria, carbuncle sore tumefacting virus.
Licorice, is the dry root and rhizome of glycyrrhizic legume, swollen fruit Radix or glycyrrhiza glabra, sweet, flat, the thoughts of returning home,
Lung, spleen, stomach;Invigorate the spleen and benefit qi, clearing heat and detoxicating, expelling phlegm and arresting coughing, relieving spasm to stop pain, coordinating the drug actions of a prescription;It is weary for weakness of the spleen and the stomach, burnout
Power, palpitation, coughing with a lot of sputum, gastral cavity abdomen, four limbs convulsion urgency pain, carbuncle sore tumefacting virus, alleviate drug toxicity, strong.
Date, is the dry mature fruit of Rhamnaceae plant jujube, sweet, temperature, is returned, spleen, stomach, the heart channel of Hang-Shaoyin;Tonifying middle-Jiao and Qi, blood-nourishing
Calm the nerves;For spleen eating less, weak loose stool, hysteria of womam.
Effective compatibility of said medicine, mutually collaboration, mutually support, with strengthening spleen, tonifying kidney, dissipating phlegm and removing blood stasis, strengthening vital QI to eliminate pathogenic factors it
Effect, is conducive to improving body's immunity, is to prevent the innovation on glioma postoperative recurrence medicine, and through clinical test and
Using, very satisfied Advantageous Effects are achieved, relevant information is as follows:
Chinese medicine composition decocting liquid is to C6(Brain glioblastoma cell)Proliferative effect research experiment data
1. experiment material
1.1 experiment cells
C6(Brain glioblastoma cell), purchased from Shanghai Inst. of Life Science, CAS cell resource center, use
RIMP1640 culture mediums and hyclone, are placed in 37 DEG C and 5% CO2Concentration incubator culture.
1.2 Experimental agents
Chinese medicine composition of the present invention.
1.3 experiment reagents
RIMP1640(GIBCO companies);NBCS(The Hangzhou four seasons clear biological engineering material Co., Ltd, lot number:
150928);0.25% trypsase(GIBCO companies);Dimethyl sulfoxide(SIGMA companies);EDTA(SIGMA companies);Cell is bred
And citotoxicity detection kit(Shanghai Bo Gu bio tech ltd, lot number:9368593);
1.4 laboratory apparatus
The double one side clean bench of SJ-CJ-2FDQ types(Suzhou purifying equipment Co., Ltd of Soviet Union);ESW-8CQ types CO2 is cultivated
Case(Thermo Fisher Scientific, the U.S.);Inverted phase contrast microscope(Leica, Germany);Accurate pipettor
(Eppendof, Germany);Low speed centrifuge(Anhui Zhong Kezhongjia scientific instrument Co., Ltd);Full-automatic high-pressure autoclave
(GR60DR, Xiamen causes micro-);Digital display three uses constant temperature water tank(Suzhou Weir experimental article Co., Ltd);The ultrapure water systems of Milli-Q
System(Merck Mi Libo);Electronic balance(XS205, plum Teller-support benefit, Switzerland);Cell counting count board;96 well culture plates;
0.2 μm of worry is first-class.
2. experimental technique
1. C6 cells are cultivated in 37 DEG C and 5% CO2 incubators with RIMP1640,10% hyclone, when cell growth to logarithm
During the phase, discard nutrient solution and washed 3 times with PBS, add trypsase and EDTA to be digested 3 minutes in 37 DEG C, be subsequently adding culture medium,
Attached cell is gently blown and beaten with pipettor to suspending completely, centrifuge tube is transferred to and is centrifuged 10 minutes in 1000rpm, adjust cell density
It is 2 × 104Individual/ml.
2. cell is added in 96 orifice plates(Per hole about 2 × 104Individual cell), it is placed in 37 DEG C and 5% CO2 incubators and cultivates
24 hours.
3. according to cell growth status, the appropriate concentration of example 1 decocting liquid is added, when continuation is incubated appropriate in incubator
Between.
4. 5 × MTT is diluted to 1 × MTT.
5. 50 μ 1 × MTT of l are added per hole, is incubated 4 hours at 37 DEG C, MTT is reduced to first month and praise.
6. supernatant is then suctioned out, adds 200 μ l DMSO the first moon is praised abundant dissolving per hole, shaken up with plate shaker.
ELIASA detects the optical density per hole at 570nm wavelength.
7. the OD values of each instrument connection are subtracted into background OD values or blank medicine hole OD values, the OD values of each repeating hole are taken the mean
± standard deviation;With cell survival rate(T/C%)To represent inhibition of the medicine to cell, T is the OD values of dosing cell, and C is right
The OD values of photo cell;Cell survival rate %=(Dosing cell OD values/compared with control cells OD values)× 100%, every group of experiment repeats three
It is secondary.
3. experimental result
Statistical result showed after the completion of MTT experiment, compares with blank control group, thin to C6 when drug dose reaches 10mg/ml
Born of the same parents' Proliferation Ability is variant(P ﹤ 0.01), there is pole significant difference when dosage is more than 15mg/ml(P ﹤ 0.001);Result is shown in
Table 1.
Table 1 is in 570nm wavelength OD values and its survival rate
Blank | Positive control | 5mg/ml | 10mg/ml | 15mg/ml | 20mg/ml | |
OD values(Mean±SD) | 0.466±0.0045 | 0.255±0.0056 | 0.412±0.0048 | 0.332±0.0041 | 0.232±0.0039 | 0.189±0.0043 |
Cell survival rate(%) | 100% | 54.7% | 88.4% | 71.2% * | 49.8% * * | 40.6% * * |
Background | 0.007 | 0.006 | 0.008 | 0.007 | 0.006 | 0.007 |
Note:Compare with control group, * P ﹤ 0.01;* P ﹤ 0.001.
4. experiment conclusion
Chinese medicine composition of the invention can suppress C6(Brain glioblastoma cell)Cell is bred, and reduces the growing number of C6 cells,
And the inhibitory action is presented drug dose dependence, and positive control drug Temozolomide has equal curative effect, but without Temozolomide
Toxic and side effect, illustrate that Chinese medicine composition of the invention inhibits the propagation of glioma cell well, prevention glioma
Postoperative recurrence has advantage.
According to clinical practical application, getting well for its curative effect did not expected that relevant clinical data was as follows.
1st, physical data:Accept Patients with gliomas 120, wherein male 73 for medical treatment altogether, women 47, age 17-72 Sui,
Average age 38 years old.By 4 grades of criteria for classifications of WHO gliomas, number of cases at different levels such as following table.
1 grade(WHO) | 2 grades(WHO) | 3 grades(WHO) | 4 grades(WHO) | |
Number of cases | 5 | 47 | 23 | 45 |
Therapeutic scheme:Chinese medicine composition of the present invention is decocted in water for oral dose, twice daily, morning and evening sub-service, each 200-300mL, one
The moon is a course for the treatment of, takes 2-3 course for the treatment of statistics curative effect.
2nd, curative effect determinate standard:
Clinical cure:Clinical symptom disappearance, imageological examination tumor disappearance does not recur in 5 years;
It is clinical effective:Clinical symptoms are most of to disappear, imageological examination tumor regression;
It is clinical effective:Clinical symptoms are relieved, and imageological examination tumour is without significant change;
It is clinical invalid:Clinical symptoms are unchanged, the increase of imageological examination tumour.
3rd, statistical procedures
Clinical cure 43 in 120 patients, effective 52, effective 17, invalid 8, total effective rate 93.3%, determined curative effect
Significantly, there are not other discomforts in patient in therapeutic process.
By the above results as can be seen that Chinese medicine composition of the present invention has the work(of strengthening spleen, tonifying kidney, dissipating phlegm and removing blood stasis, strengthening vital QI to eliminate pathogenic factors
Effect, is conducive to improving body's immunity, controls tumor proliferation, and attenuation synergistic, prevention recurrence extends life cycle, is prevention brain
Innovation on After gliomas operation recurrence medicine, compared with prior art, with following Advantageous advantage:
(1)The effect of this formula has strengthening spleen, tonifying kidney, dissipating phlegm and removing blood stasis, strengthening vital QI to eliminate pathogenic factors, collectively promotes the vigorous of human righteousness, favorably
In raising body's immunity;
(2)Chinese medicine in the present invention is natural botanical source, and security is good, there is actual economic worth and clinical value, is
With the innovation on traditional Chinese medicine prevention glioma postoperative recurrence;
(3)Low cost of the present invention, material medicine enriches, prepared by easily production;
(4)Easy to use, effect is good, and curative effect is up to more than 93%, strong beneficial to body with very strong actual application value
Health, beneficial to industrialized production and commercial popularization, obtains business success, there is good economic and social benefit.
Claims (9)
1. it is a kind of prevent glioma postoperative recurrence Chinese medicine composition, it is characterised in that by the raw material of following parts by weight meter
Medicine is made:Radix Codonopsis 1-8 parts, root of large-flowered skullcap 1-5 parts, Os Draconis 1-5 parts, raw oyster 1-5 parts, cassia twig 1-15 parts, Poria cocos 1-10 parts, clearly
Tuber of pinellia 1-5 parts, radix bupleuri 1-8 parts, rheum officinale 1-15 parts, fry two ugly 1-5 parts, moutan bark 1-7 parts, gypsum 1-15 parts, gypsum rubrum 1-5
Part, rhizoma zingiberis 1-7 parts, great Bei 1-7 parts, radix scrophulariae 1-10 parts, licorice 1-8 parts and date 1-5 parts, wherein, first will be except Os Draconis, life
Other 16 taste material medicines of oyster are mixed, and add the water of other 7-10 times of 16 taste material medicine weight, soak 30-
60min;Os Draconis, raw oyster are mixed, plus Os Draconis, the water of 7-10 times of raw oyster weight, 30-60min is soaked, decoct
30-40min is boiled, in other the 16 taste material medicines poured into after immersion 30-60min, then 30-40min is decocted, filtered, obtain first
Secondary filtrate;The dregs of a decoction add the water of 7-10 times of material medicine weight, decoct 30-40min, filter to obtain second filtrate, merge two
Secondary filtrate, is mixed into Chinese medicine liquid.
2. it is according to claim 1 prevention glioma postoperative recurrence Chinese medicine composition, it is characterised in that by following heavy
The material medicine for measuring number meter is made:7 parts of Radix Codonopsis, 4 parts of the root of large-flowered skullcap, 4 parts of Os Draconis, 4 parts of raw oyster, 8 parts of cassia twig, 8 parts of Poria cocos, clearly
4 parts of the tuber of pinellia, 6 parts of radix bupleuri, 9 parts of rheum officinale, ugly 4 parts of stir-fry two, 6 parts of moutan bark, 9 parts of gypsum, 4 parts of gypsum rubrum, 6 parts of rhizoma zingiberis, great Bei 5
3 parts of part, 8 parts of radix scrophulariae, 6 parts of licorice and date, preparation method is with claim 1.
3. it is according to claim 1 prevention glioma postoperative recurrence Chinese medicine composition, it is characterised in that by following heavy
The material medicine for measuring number meter is made:5 parts of Radix Codonopsis, 6 parts of the root of large-flowered skullcap, 3 parts of Os Draconis, 3 parts of raw oyster, 5 parts of cassia twig, 3 parts of Poria cocos, clearly
6 parts of the tuber of pinellia, 4 parts of radix bupleuri, 5 parts of rheum officinale, ugly 6 parts of stir-fry two, 4 parts of moutan bark, 5 parts of gypsum, 6 parts of gypsum rubrum, 3 parts of rhizoma zingiberis, great Bei 3
6 parts of part, 6 parts of radix scrophulariae, 4 parts of licorice and date, preparation method is with claim 1.
4. it is according to claim 1 prevention glioma postoperative recurrence Chinese medicine composition, it is characterised in that by following heavy
The material medicine for measuring number meter is made:3 parts of Radix Codonopsis, 4 parts of the root of large-flowered skullcap, 2 parts of Os Draconis, 2 parts of raw oyster, 4 parts of cassia twig, 4 parts of Poria cocos, clearly
2 parts of the tuber of pinellia, 3 parts of radix bupleuri, 4 parts of rheum officinale, ugly 3 parts of stir-fry two, 5 parts of moutan bark, 7 parts of gypsum, 3 parts of gypsum rubrum, 5 parts of rhizoma zingiberis, great Bei 3
5 parts of part, 2 parts of radix scrophulariae, 8 parts of licorice and date, preparation method is with claim 1.
5. it is according to claim 1 prevention glioma postoperative recurrence Chinese medicine composition, it is characterised in that by following heavy
The material medicine for measuring number meter is made:2 parts of Radix Codonopsis, 3 parts of the root of large-flowered skullcap, 3 parts of Os Draconis, 3 parts of raw oyster, 2 parts of cassia twig, 2 parts of Poria cocos, clearly
3 parts of the tuber of pinellia, 3 parts of radix bupleuri, 2 parts of rheum officinale, ugly 2 parts of stir-fry two, 2 parts of moutan bark, 6 parts of gypsum, 2 parts of gypsum rubrum, 3 parts of rhizoma zingiberis, great Bei 2
Part, 3 parts of radix scrophulariae, 3 parts of licorice, 5 parts of date, preparation method is with claim 1.
6. it is according to claim 1 prevention glioma postoperative recurrence Chinese medicine composition, it is characterised in that by following heavy
The material medicine of gauge is made:Radix Codonopsis 100g, root of large-flowered skullcap 100g, Os Draconis 300g, raw oyster 300g, cassia twig 100g, Poria cocos 120g,
Prepared RHIZOMA PINELLIZE without adju-vant 100g, radix bupleuri 100g, rheum officinale 100g, fry two ugly 60g, moutan bark 100g, gypsum 300g, gypsum rubrum 100g, rhizoma zingiberis
100g, great Bei 100g, radix scrophulariae 300g, licorice 60g and date 200g, preparation method is with claim 1.
7. it is according to claim 1 prevention glioma postoperative recurrence Chinese medicine composition, it is characterised in that by following heavy
The material medicine of gauge is made:Radix Codonopsis 200g, root of large-flowered skullcap 200g, Os Draconis 100g, raw oyster 100g, cassia twig 200g, Poria cocos 150g,
Prepared RHIZOMA PINELLIZE without adju-vant 200g, radix bupleuri 200g, rheum officinale 200g, fry two ugly 100g, moutan bark 200g, gypsum 100g, gypsum rubrum 200g, rhizoma zingiberis
200g, great Bei 200g, radix scrophulariae 100g, licorice 100g and date 100g, preparation method is with claim 1.
8. it is according to claim 1 prevention glioma postoperative recurrence Chinese medicine composition, it is characterised in that by following heavy
The material medicine of gauge is made:Radix Codonopsis 50g, root of large-flowered skullcap 50g, Os Draconis 150g, raw oyster 150g, cassia twig 50g, Poria cocos 50g, clear half
Summer 60g, radix bupleuri 60g, rheum officinale 60g, fry two ugly 30g, moutan bark 50g, gypsum 150g, gypsum rubrum 50g, rhizoma zingiberis 50g, great Bei
60g, radix scrophulariae 150g, licorice 100g and date 80g, preparation method is with claim 1.
9. it is according to claim 1 prevention glioma postoperative recurrence Chinese medicine composition, it is characterised in that by following heavy
The material medicine of gauge is made:Radix Codonopsis 30g, root of large-flowered skullcap 30g, Os Draconis 80g, raw oyster 80g, cassia twig 30g, Poria cocos 40g, prepared RHIZOMA PINELLIZE without adju-vant
40g, radix bupleuri 20g, rheum officinale 30g, fry two ugly 20g, moutan bark 30g, gypsum 50g, gypsum rubrum 40g, rhizoma zingiberis 30g, great Bei 30g,
Radix scrophulariae 20g, licorice 30g and date 30g, preparation method is with claim 1.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111472441.8A CN113967244A (en) | 2017-03-16 | 2017-03-16 | Traditional Chinese medicine composition and medicine for preventing postoperative recurrence of glioma, and preparation method and application thereof |
CN201710156755.4A CN106822844A (en) | 2017-03-16 | 2017-03-16 | A kind of Chinese medicine composition of prevention glioma postoperative recurrence |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710156755.4A CN106822844A (en) | 2017-03-16 | 2017-03-16 | A kind of Chinese medicine composition of prevention glioma postoperative recurrence |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111472441.8A Division CN113967244A (en) | 2017-03-16 | 2017-03-16 | Traditional Chinese medicine composition and medicine for preventing postoperative recurrence of glioma, and preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106822844A true CN106822844A (en) | 2017-06-13 |
Family
ID=59144146
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111472441.8A Pending CN113967244A (en) | 2017-03-16 | 2017-03-16 | Traditional Chinese medicine composition and medicine for preventing postoperative recurrence of glioma, and preparation method and application thereof |
CN201710156755.4A Pending CN106822844A (en) | 2017-03-16 | 2017-03-16 | A kind of Chinese medicine composition of prevention glioma postoperative recurrence |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111472441.8A Pending CN113967244A (en) | 2017-03-16 | 2017-03-16 | Traditional Chinese medicine composition and medicine for preventing postoperative recurrence of glioma, and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN113967244A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104491060A (en) * | 2014-12-05 | 2015-04-08 | 泰山医学院 | Tradtional Chinese medicine for preventing relapse of glioma |
-
2017
- 2017-03-16 CN CN202111472441.8A patent/CN113967244A/en active Pending
- 2017-03-16 CN CN201710156755.4A patent/CN106822844A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104491060A (en) * | 2014-12-05 | 2015-04-08 | 泰山医学院 | Tradtional Chinese medicine for preventing relapse of glioma |
Non-Patent Citations (1)
Title |
---|
李佩文等: "《中医肿瘤临床手册》", 30 April 2006, 上海科学技术出版社 * |
Also Published As
Publication number | Publication date |
---|---|
CN113967244A (en) | 2022-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104474471A (en) | Traditional Chinese medicine composition for treating thyroid | |
CN104784673B (en) | A kind of Chinese traditional medicine navel for infantile diarrhea pastes | |
CN105327205A (en) | Traditional Chinese medicine preparation for treating thyroid cancer | |
CN103751482A (en) | Medicine for treating postpartum abdominal pain and preparation method thereof | |
CN104857238A (en) | Traditional Chinese medicine for treating spleen-kidney-yang deficiency type iron-deficiency anemia and preparation method | |
CN104784549A (en) | Traditional Chinese medicine for treating allergic rhinitis | |
CN103520673B (en) | Traditional Chinese medicine for treating deficiency of Qi and blood syndrome type of menopathy | |
CN102614466B (en) | Traditional Chinese medical preparation for treatment of lung adenocarcinoma | |
CN106822844A (en) | A kind of Chinese medicine composition of prevention glioma postoperative recurrence | |
CN104771585A (en) | Traditional Chinese medicine composition for treating acute nephritis and preparation method thereof | |
CN104524277A (en) | Traditional Chinese medicine mixture for treating anorexia nervosa | |
CN104225569A (en) | Chinese medicinal composition for treating chronic enteritis | |
CN104771733B (en) | A kind of Chinese medicine composition for treating chronic bronchitis | |
CN104740499A (en) | Traditional Chinese medicine oral decoction for treating lung cancer | |
CN103239556A (en) | Traditional Chinese medicine for treating cervical spondylosis caused by wind-cold-dampness arthralgia | |
CN103230547A (en) | Traditional Chinese medicine for treating intractable hiccup | |
CN102743682B (en) | Chinese medicinal pill for preventing miscarriage of pregnant woman | |
CN109464628A (en) | A kind of Chinese medicine composition for treating insomnia | |
CN102357160B (en) | Chinese medicine for treating malaria | |
CN105125786A (en) | Traditional Chinese medicine preparation for treating hyperplasia of mammary glands and preparation method thereof | |
CN105327299A (en) | Medicine for treating idiopathic thrombocytopenic purpura | |
CN104922595A (en) | Traditional Chinese medicinal preparation for herpes zoster and preparation method thereof | |
CN104491537A (en) | Traditional Chinese medicine composition for treating rheumatic heart disease | |
CN104524417A (en) | Medicine for treating recurrent oral ulceration | |
CN104784563A (en) | Traditional Chinese medicine preparation for treating amygdalitis and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170613 |